[{"Assets_0_Q2_USD":42765705.0,"CommonStockSharesOutstanding_0_Q2_shares":33184710.0,"NetIncomeLoss_2_Q2_USD":-5822204.0,"NetIncomeLoss_1_Q2_USD":-2060179.0,"StockholdersEquity_0_Q2_USD":11308754.0,"Ticker":"AXGN","CIK":"805928","name":"AXOGEN, INC.","OfficialName":"Axogen Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"313567338.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20170802"}]